5 Stocks Approaching Greatness

Recs

10

Disney Buys Marvel!

David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT.

Some companies are obviously great investments -- in hindsight. Yet for every stock out there screaming "buy me," others simply give us a nudge and a nod. How can we tell tomorrow's obviously great investments from the thousands of pretenders?

The stars' walk of fame
On Motley Fool CAPS, these opportunities can be found among our four-star stocks. In CAPS' proprietary ratings system, they rank higher than most of the other 5,300 starred companies, but they're just shy of superstardom. While all the attention might be focused on their five-star peers, we can sift through CAPS to find four-star firms approaching greatness. Here are a handful we’ve discovered recently.

  • Accuray (Nasdaq: ARAY)
  • Caterpillar (NYSE: CAT)
  • Level 3 Communications (Nasdaq: LVLT)
  • Nuance Communications (Nasdaq: NUAN)
  • Yingli Green Energy (NYSE: YGE)

Some of these names might surprise you. Level 3 Communications has been a leading player in fiber optics and in operating one of the largest backbone networks. Almost great? Even familiar names can still offer some of the best opportunities. Perhaps we've just forgotten the potential they still hold. However, the 135,000-plus CAPS members chose these companies as less obvious sources for tomorrow's great buys, so let's see why they might merit your attention.

In the sight of greatness?
There was enough hope for recovery in July's housing numbers to lift construction vehicle maker Caterpillar. Falling prices boosted existing home sales 7.2% last month, spurring a 3% increase in Caterpillar's stock, as investors believe there will be more need for its vehicles. The heavy equipment maker needed some good news, since total sales dropped 47% in the last quarter, with North America's numbers tumbling further, falling 59% from the year-ago period.

In particular, the truck segment has been weighing down Caterpillar's operations. The U.S. truck market dropped 32% through July of this year, while Cat's own truck segment plummeted 72%. Things have been so bad in the segment that Caterpillar announced last year it would be withdrawing from supplying engines to the truck market by 2010.

Coupled with the housing numbers, China might signal a reversal of fortunes. Over the first seven months of 2009, truck sales there have risen 23%, which makes Caterpillar's new deal with Navistar (NYSE: NAV) an important introduction to that market. The two vehicle makers will be teaming up with Anhui Jianghuai Automobile Company to produce medium and heavy-duty trucks and engines for the Chinese market, but CAPS member shreebs thinks the China connection has been overplayed:

Has had a great run with this overextended mkt banking on a V shaped economic recover, which will not happen and when the mkt realizes that,soon it will be back down the slide for a little while. Also the assumption that China will create continuous demand for infrastructure build is also a little overhyped...

A bright future
Last week, Yingli Green Energy reported that it was shipping a lot more product at reduced prices, resulting in reduced margins. Some smart Fools think this amounts to much ado about nothing and believe the selloff in the stock was reactionary. Yingli might still face pressure when it comes down to competing against its closest rival, Trina Solar (NYSE: TSL).

Trina's already written down its inventory, and Yingli proudly says it has not. But with lower polysilicon prices now firmly fixed in the marketplace, the potential for Yingli's margins to improve looks weak. On the other hand, Trina is better positioned because its per-watt costs for non-silicon manufacturing for multicrystalline products are lower than Yingli's $0.90 per watt. There is simply a lot of supply in the market that needs to be worked out, and solar companies may be a little too enthusiastic about future shipments.

Still, CAPS member STows99 thinks the company’s presence in the U.S. complements its Chinese position, and that subsidies from overseas will keep it flush with cash:

YGE is the leading solar company in China. It has branched and grown into the USA with bicoastal offices in the major cities of each. That says something about the management of the company, they know that Green Energy is an up and coming movement and there is a lot of money to be made on it. Their success is complimented by the willingness of the Chinese government to credit these kinds of companies like YGE with government subsidies to help them grow. All in all YGE is a good bet, in it to win it, and a solid long term investment.

A great opportunity for you
Investor sentiment suggests these four-star investments still seem to be on their way to five-star greatness, but it pays to start your own research on these stocks on Motley Fool CAPS. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made, all from a stock's CAPS page.

Sign up today for the completely free service and let us hear what you have to say about the great -- and almost great -- companies that interest you.

“The Death of the Euro!”…Greece may seem worlds away, but be warned. What happens there next could reshape global finance and rattle your portfolio. On Mar. 22, The Motley Fool’s Tim Hanson heads to Greece to get the story. Follow in real time and hear how best to profit from this historic development (Hanson returned from China in July with a stock that’s up 117%!). Enter email below.

Nuance Communications is a Motley Fool Hidden Gems selection. Try any of our Foolish newsletter services today, free for 30 days.

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool has a gold-plated disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 25, 2009, at 11:36 AM, PauvrePapillon wrote:

    Buying Opportunity Today for Accuray

    Those small (newsletter reading) investors in a panic today over the $0.01 EPS miss simply do not understand either the accounting rules or the fact that the financial condition of the company is clearly improving. They have no idea that large ticket medical device companies like Accuray operate under arcane revenue recognition rules that have the effect of separating posted revenues and earnings from present results by several quarters. You have to look at cash flow to see how you really are doing. Institutional investors who did their homework will not be surprised by the Platinum Plan workout and, if they were inclined to want to add to their positions, will take this a buying opportunity.

    Because of the way the revenues are recognized for this type of company, neither the quarterly revenue nor the EPS are really all that important at this stage. What’s important is the fact that the cash flow is positive – to the tune of $2 million in this past quarter – while the installed base, patient demand and recurring revenues all continue to increase.

    With respect to guidance for fiscal 2010, Accuray is managing its way through a transition out of deferred revenues recognized out of the now obsolete (and non-cash producing) Platinum Plan, which was used to incentivize early, post-investigational device (IDE) adopters, to new revenues, which are both cash producing and with respect to most all of the domestic installs include a recurring component as well.

    If guidance is correct, fiscal 2010 will see a substantial increase in net free cash flow as approximately $38 million in Platinum Plan non-cash producing revenues are replaced with approximately $20 to $30 million of new cash producing revenues. There were also $5.8 million in non-recurring charges during fiscal 2009 that, hopefully, will not be repeated in 2010. Bottom line: you have something like $25 to $35 million in additional cash flow cued up for fiscal 2010 that didn’t happen in 2009.

    Cash producing revenues exclusive of Platinum Plan and one-time bulk sale revenues grew at a rate of 14.5 percent from fiscal 2008 to 2009 and are projected to grow at a rate of 15 percent from fiscal 2009 to 2010. A steady 15 percent growth rate in cash producing revenues is impressive given all of the uncertainties that Accuray’s main customers are facing in the current macro economic environment.

    Backlog is no cause for concern. Management has been tightening up its backlog calculations as it gains more experience with the order and install process of this particular product. This is to be expected. The slight drop off in backlog is more the result of a tighter definition of non-contingent contracts than orders actually falling out of the pipeline. New order growth is more than sufficient to maintain the 15 percent growth rate. Accuray added 15 new contracts worth about $75 million during the last quarter. Non-contingent backlog still exceeds $400 million. When the company went public, that number was closer to $300 million.

    It’s also very important to note that management has continued to grow cash-producing revenues at a 15 percent clip despite headwinds in the form of difficulties with bank financing, controversies over reimbursements as well as uncertainties with respect to the healthcare system in general. With both Obama and Obamacare now tanking in the polls, there is a good chance of seeing at least some relief from these conditions sometime over the next 12 months. The recent Palmeto and First Coast CyberKnife for prostate Medicare coverage decisions are also signs that Accuray is making headway in the reimbursement area.

    Also impressive are the recurring revenues, which are fast approaching $20 million per quarter and now account for nearly one-third of total revenue. As Accuray continues to add to its installed base, these recurring revenues will begin to overtake their SG&A expense and the company’s operating margins and EPS will benefit greatly.

    There is a lot of discussion at the small investor level of the impact of non-cash compensation charges to EPS but not a lot of angst coming from the institutional side. My guess is that this is because the institutional investors are more focused on the steady growth of cash-producing revenues than the drop off in non-cash producing deferred revenue recognition and more interested in management’s continued successful rollout of their CyberKnife technology while maintaining a strong balance sheet than in the sort of strictly EPS-oriented financial results that drive share price for more mature companies such as Varian and Intuitive Surgical.

    Again, if you look at the rollout of Intuitive Surgical, they had the same problems – only more so. The exodus of small players will hammer the stock today and provide an excellent entry point for new money as well as for existing shareholders who see the big picture to add to their positions.

    All it will take is one big quarter to blast this stock off the launching pad. Until then, it just takes patience and conviction, which should be easy to come by especially if you stay focused on the cash flow - which is both positive and improving.

  • Report this Comment On August 25, 2009, at 4:19 PM, sfmaestro wrote:

    I suppose one reason for recommending YGE is that it has dropped 20% since it was first recommended to the gullible investors in Fool, like me. So, NOW, it is much better investment than when you first mentioned it. Pity for us poor fools who listened the first time round and are now sitting on a substantial loss. There seems to be some weird Murphy's Law applicable here. When I sit and watch a stock you recommend, (like CGA) it shoots up out of reach within days. When I go for it asap it drops like a stone. It's a hard life.

  • Report this Comment On August 26, 2009, at 1:09 AM, PauvrePapillon wrote:

    When the market (correctly) understood that CyberKnife was a truly unique and revolutionary technology, investors bid Accuray’s post-IPO shares up to an intraday high of $31.09 (9 February 2007). As Varian and others made repeated claims, in numerous press releases, interviews and conference calls, that their gantry-mounted machines could do the same thing as the robotically controlled CyberKnife, Accuray’s market cap shrank even though its economic fundamentals actually improved.

    On 6 December 2008, Accuray, finally, fired back with the release of two animated videos that effectively demonstrate what CyberKnife is and why it is fundamentally different from gantry-mounted radiation sprayers. You can see them for yourself at http://www.accuray.com.

    Since the release of Accuray’s technology differentiation videos (6 December 2008) through close of market today:

    ARAY is up 60.49 percent

    NASDAQ is up 34.13 percent

    TOMO is up 24.76 percent

    DOW is up 10.47 percent

    VAR is down 4.80 percent

    Even after today’s sell off, Accuray is still outperforming VAR, TOMO, DOW, TOMO and the NASDAQ and is not far behind ISRG (up 66.94 percent).

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 970824, ~/Articles/ArticleHandler.aspx, 3/21/2010 2:55:07 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 10,741.98 -37.19 -0.35%
S&P 500 1,159.90 -5.92 -0.51%
NASD 2,374.41 -16.87 -0.71%

Related Tickers

3/19/2010 4:02 PM
TSL $21.30 Up +0.76 +3.70%
Trina Solar Limite… CAPS Rating: **
CAT $59.37 Down -0.40 -0.67%
Caterpillar, Inc. CAPS Rating: ****
NAV $41.92 Down -0.37 -0.87%
Navistar Internati… CAPS Rating: **
YGE $11.88 Up +0.02 +0.17%
Yingli Green Energ… CAPS Rating: ****
NUAN $17.08 Up +0.03 +0.18%
Nuance Communicati… CAPS Rating: ****
LVLT $1.68 Down -0.07 -4.00%
Level 3 Communicat… CAPS Rating: ****
ARAY $6.92 Down -0.39 -5.34%
Accuray, Inc. CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Market price: The market price is the current value of the asset in question, usually as determined by recent transactions on an exchange or similar market.

Want to learn more or edit this definition?
Click here to read more!